DrugDashboards
← Home
Manufacturing facility

Lupin Limited

A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.

Country
India
Registered address
Unit-1, Plot No. 6A1, 6A2, Sector - 17, Special Economic Zone, Mihan, Nagpur, Maharashtra 441108, India (IND)
Operations here
manufacturepack
FDA identifiers
FEI 3009843207 · DUNS 650759348

FDA inspection history

Outcomes of closed FDA inspections at this site (drug and biologic program areas).

  • VAIDrug Quality Assurance2023-07-11
  • NAIDrug Quality Assurance2019-08-08
  • NAIDrug Quality Assurance2018-05-11
  • NAIDrug Quality Assurance2015-03-27

Drugs this plant is listed as making

27 distinct drugs across 85 products name this site in their FDA label.

Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.